Endogenous testosterone and mortality in men: A systematic review and meta-analysis

ContextLow testosterone levels have been associated with outcomes that reduce survival in men.ObjectiveOur objective was to perform a systematic review and meta-analysis of published studies to evaluate the association between endogenous testosterone and mortality.Data sourcesData sources included MEDLINE (1966 to December 2010), EMBASE (1988 to December 2010), and reference lists.Study selectionEligible studies were published English-language observational studies of men that reported the association between endogenous testosterone and all-cause or cardiovascular disease (CVD) mortality. A two-stage process was used for study selection. 1) Working independently and in duplicate, reviewers screened a subset (10%) of abstracts. Results indicated 96% agreement, and thereafter, abstract screening was conducted in singlicate. 2) All full-text publications were reviewed independently and in duplicate for eligibility.Data extractionReviewers working independently and in duplicate determined methodological quality of studies and extracted descriptive, quality, and outcome data.Data synthesisOf 820 studies identified, 21 were included in the systematic review, and 12 were eligible for meta-analysis [n = 11 studies of all-cause mortality (16,184 subjects); n = 7 studies of CVD mortality (11,831 subjects)]. Subject mean age and testosterone level were 61 yr and 487 ng/dl, respectively, and mean follow-up time was 9.7 yr. Between-study heterogeneity was observed among studies of all-cause (P ConclusionLow endogenous testosterone levels are associated with increased risk of all-cause and CVD death in community-based studies of men, but considerable between-study heterogeneity, which was related to study and subject characteristics, suggests that effects are driven by differences between cohorts (e.g. in underlying health status).Andre B. Araujo, Julia M. Dixon, Elizabeth A. Suarez, M. Hassan Murad, Lin T. Guey, and Gary A. Witter